Phase 3 Readout
CMPS: Phase 3 Topline: A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Sa
December 1, 2026. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 1, 2026
- Company
- COMPASS Pathways plc (CMPS)
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Sa
- Company
- COMPASS Pathways plc (CMPS)
- Indication
- Treatment Resistant Depression